Polymorphisms of RANTES and IL-4 Genes in Cerebral Infarction

Overview

Journal J Mol Neurosci

Specialties Molecular Biology
Neurology

Date 2008 Aug 13

PMID 18696265

Citations 4

Authors

Jae-Young Um

Hyung-Min Kim

Affiliations

Soon will be listed here.

Abstract

Chemoattractant peptides (chemokines) and cytokines have been shown to play a key role in the inflammatory development and progression of cerebrovascular disease. The effect of polymorphisms in regulated upon activation, normal T cells expressed, and secreted (RANTES) and interleukin-4 (IL-4) genes on cerebral infarction (CI) is evaluated in this study. Patients with CI (n = 320) and healthy controls (n = 481) were genotyped for RANTES-403 and IL-4 variable number of tandem repeat (VNTR) polymorphisms using polymerase chain reaction (PCR) or PCR-restriction fragment length polymorphism. A significant difference was observed between the CI group and controls in subjects with the RANTES AA genotype in IL-4 A3- carriers (18.6% vs. 13.1%, P = 0.035, odds ratio = 1.5, 95% confidence interval = 1.03-2.25). These findings suggest that the RANTES G-403A allele increased the relative risk for CI in the subjects without the IL-4 VNTR allele 3.

Citing Articles

Chemokine Ligand 5 (CCL5) Derived from Endothelial Colony-Forming Cells (ECFCs) Mediates Recruitment of Smooth Muscle Progenitor Cells (SPCs) toward Critical Vascular Locations in Moyamoya Disease.

Phi J, Suzuki N, Moon Y, Park A, Wang K, Lee J PLoS One. 2017; 12(1):e0169714.

PMID: 28072843 PMC: 5224827. DOI: 10.1371/journal.pone.0169714.

Interleukin-6 Receptor Polymorphisms Contribute to the Neurological Status of Korean Patients with Ischemic Stroke.

Kim D, Yoo S, Chon J, Yun D, Kim H, Park H J Korean Med Sci. 2016; 31(3):430-4.

PMID: 26955245 PMC: 4779869. DOI: 10.3346/jkms.2016.31.3.430.

Assessment of two missense polymorphisms (rs4762 and rs699) of the angiotensinogen gene and stroke.

Park H, Kim M, Kim S, Jo D Exp Ther Med. 2012; 5(1):343-349.

PMID: 23251296 PMC: 3524280. DOI: 10.3892/etm.2012.790.

Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice.

Denes A, Humphreys N, Lane T, Grencis R, Rothwell N J Neurosci. 2010; 30(30):10086-95.

PMID: 20668193 PMC: 3044869. DOI: 10.1523/JNEUROSCI.1227-10.2010.

References

Valentin A, Lu W, Rosati M, Schneider R, Albert J, Karlsson A . Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression. Proc Natl Acad Sci U S A. 1998; 95(15):8886-91. PMC: 21172. DOI: 10.1073/pnas.95.15.8886. View

Wang J, Harada A, Matsushita S, Matsumi S, Zhang Y, Shioda T . IL-4 and a glucocorticoid up-regulate CXCR4 expression on human CD4+ T lymphocytes and enhance HIV-1 replication. J Leukoc Biol. 1998; 64(5):642-9. DOI: 10.1002/jlb.64.5.642. View

Mout R, Willemze R, Landegent J . Repeat polymorphisms in the interleukin-4 gene (IL4). Nucleic Acids Res. 1991; 19(13):3763. PMC: 328438. DOI: 10.1093/nar/19.13.3763. View

Qin S, Rottman J, Myers P, Kassam N, Weinblatt M, Loetscher M . The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest. 1998; 101(4):746-54. PMC: 508621. DOI: 10.1172/JCI1422. View

Al Sharif F, Ollier W, Hajeer A . A rare polymorphism at position -28 in the human RANTES promoter. Eur J Immunogenet. 1999; 26(5):373-4. DOI: 10.1046/j.1365-2370.1999.00162.x. View

Vandenbroeck K, Martino G, Marrosu M, Consiglio A, Zaffaroni M, Vaccargiu S . Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis. J Neuroimmunol. 1997; 76(1-2):189-92. DOI: 10.1016/s0165-5728(97)00058-1. View

Simeoni E, Winkelmann B, Hoffmann M, Fleury S, Ruiz J, Kappenberger L . Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J. 2004; 25(16):1438-46. DOI: 10.1016/j.ehj.2004.05.005. View

Wang J, Roderiquez G, Oravecz T, Norcross M . Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J Virol. 1998; 72(9):7642-7. PMC: 110028. DOI: 10.1128/JVI.72.9.7642-7647.1998. View

Tanaka Y, Koyanagi Y, Tanaka R, Kumazawa Y, Nishimura T, Yamamoto N . Productive and lytic infection of human CD4+ type 1 helper T cells with macrophage-tropic human immunodeficiency virus type 1. J Virol. 1997; 71(1):465-70. PMC: 191073. DOI: 10.1128/JVI.71.1.465-470.1997. View

10.

Hegab A, Sakamoto T, Saitoh W, Massoud H, Massoud H, Hassanein K . Polymorphisms of IL4, IL13, and ADRB2 genes in COPD. Chest. 2004; 126(6):1832-9. DOI: 10.1378/chest.126.6.1832. View

11.

Schall T, Bacon K . Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol. 1994; 6(6):865-73. DOI: 10.1016/0952-7915(94)90006-x. View

12.

Mach F . The role of chemokines in atherosclerosis. Curr Atheroscler Rep. 2001; 3(3):243-51. DOI: 10.1007/s11883-001-0067-y. View

13.

Martin M, Dean M, Smith M, Winkler C, Gerrard B, Michael N . Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science. 1998; 282(5395):1907-11. DOI: 10.1126/science.282.5395.1907. View

14.

Veillard N, Kwak B, Pelli G, Mulhaupt F, James R, Proudfoot A . Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res. 2003; 94(2):253-61. DOI: 10.1161/01.RES.0000109793.17591.4E. View

15.

Saijo Y, Sata F, Yamada H, Konodo T, Kato E, Kataoka S . Interleukin-4 gene polymorphism is not involved in the risk of recurrent pregnancy loss. Am J Reprod Immunol. 2004; 52(2):143-6. DOI: 10.1111/j.1600-0897.2004.00193.x. View

16.

Kim J, Lee J, Jang C, Kim Y, Cheon Chae S, Chung H . Chemokine RANTES promoter polymorphisms in allergic rhinitis. Laryngoscope. 2004; 114(4):666-9. DOI: 10.1097/00005537-200404000-00013. View

17.

Fryer A, Spiteri M, Bianco A, Hepple M, Jones P, Strange R . The -403 G-->A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun. 2001; 1(8):509-14. DOI: 10.1038/sj.gene.6363717. View

18.

Chomarat P, Vannier E, Dechanet J, Rissoan M, Banchereau J, Dinarello C . Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol. 1995; 154(3):1432-9. View

19.

Le Beau M, Lemons R, Espinosa 3rd R, Larson R, Arai N, Rowley J . Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Blood. 1989; 73(3):647-50. View

20.

Hendel H, Henon N, Lebuanec H, Lachgar A, Poncelet H, Caillat-Zucman S . Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 19(4):381-6. DOI: 10.1097/00042560-199812010-00009. View